Source: BioSpace

Sentrx Animal Care: Kiora Pharmaceuticals and Sentrx Animal Care Amend Existing Manufacturing Licensing Agreement for KIO-201

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora") and Sentrx Animal Care ("Sentrx") announced today they have amended their existing licensing agreement for patents and technology related to Kiora's KIO-201 product candidate

Read full article »
Sentrx Animal Care's Competitors | Sentrx Animal Care's News | Sentrx Animal Care's Financials
Stay up-to-date with the latest news on Sentrx
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Anne Moulin's photo - President of Sentrx

President

Anne Moulin

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on Sentrx